D. Boral Capital Maintains Buy on AVITA Medical, Maintains $19 Price Target

Benzinga · 06/06 11:13
D. Boral Capital analyst Jason Kolbert maintains AVITA Medical (NASDAQ:RCEL) with a Buy and maintains $19 price target.